ShangPharma Innovation Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire ShangPharma Innovation Inc.
Quantité totale PI 22
Rang # Quantité totale PI 68 579
Note d'activité PI 2,2/5.0    18
Rang # Activité PI 45 923
Classe Nice dominante Publicité; Affaires commerciales

Brevets

Marques

9 1
5 0
7 0
0
 
Dernier brevet 2025 - Caspase 6 inhibitors and uses th...
Premier brevet 2018 - Peptide compound and application...
Dernière marque 2018 - PANDECT
Première marque 2018 - PANDECT

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 Invention Anti-urokinase-type plasminogen activator receptor antibodies and methods of use. Provided are an...
Invention Anti-urokinase-type plasminogen activator receptor antibodies and methods of use
2022 Invention Small molecules inhibitors of cyclic gmp-amp synthase (cgas). Provided herein are compounds of F...
Invention Small molecules inhibitors of cyclic gmp-amp synthase (cgas). Provided herein are compounds of Fo...
Invention Peptide compound and application thereof, and composition containing peptide compound. Disclosed ...
Invention Peptide compound and application thereof, and composition containing peptide compound. 2
2021 Invention Rev-erb agonists for the treatment of th17-mediated inflammatory disorders. The present disclosu...
Invention Rev-erb agonists for the treatment of th17-mediated inflammatory disorders. The present disclosur...
Invention Inhibitors of alpha 2 beta 1 integrin and methods of use thereof. Disclosed herein, inter alia, a...
Invention Inhibitors of alpha 2 beta 1 integrin and methods of use thereof. inter aliainter alia, are inhib...
Invention Strad-binding agents and uses thereof. Disclosed herein, inter alia, are compounds for binding ST...
Invention Strad-binding agents and uses thereof. inter aliainter alia, are compounds for binding STRAD pseu...
2020 Invention Caspase 6 inhibitors and uses thereof. Disclosed herein, inter alia, are compounds and methods f...
Invention Caspase 6 inhibitors and uses thereof. Disclosed herein, inter alia, are compounds and methods fo...
Invention Nurr1 receptor modulators. Described herein, inter alia, are Nurr1 receptor modulators and uses ...
Invention Nurr1 receptor modulators. Described herein, inter alia, are Nurr1 receptor modulators and uses t...
2018 P/S Business management and consulting services Venture capital investment, advisory and management s...
Invention Peptide compound and application thereof, and composition containing peptide compound. Cap-AA1-A...